BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19107118)

  • 1. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
    Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
    Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
    Cheng JC; Bai A; Beckham TH; Marrison ST; Yount CL; Young K; Lu P; Bartlett AM; Wu BX; Keane BJ; Armeson KE; Marshall DT; Keane TE; Smith MT; Jones EE; Drake RR; Bielawska A; Norris JS; Liu X
    J Clin Invest; 2013 Oct; 123(10):4344-58. PubMed ID: 24091326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.
    Turner LS; Cheng JC; Beckham TH; Keane TE; Norris JS; Liu X
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):30-7. PubMed ID: 21116286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid ceramidase as a therapeutic target in metastatic prostate cancer.
    Camacho L; Meca-Cortés O; Abad JL; García S; Rubio N; Díaz A; Celià-Terrassa T; Cingolani F; Bermudo R; Fernández PL; Blanco J; Delgado A; Casas J; Fabriàs G; Thomson TM
    J Lipid Res; 2013 May; 54(5):1207-20. PubMed ID: 23423838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
    Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
    Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
    Elojeimy S; Liu X; McKillop JC; El-Zawahry AM; Holman DH; Cheng JY; Meacham WD; Mahdy AE; Saad AF; Turner LS; Cheng J; A Day T; Dong JY; Bielawska A; Hannun YA; Norris JS
    Mol Ther; 2007 Jul; 15(7):1259-63. PubMed ID: 17426710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.
    Nava VE; Cuvillier O; Edsall LC; Kimura K; Milstien S; Gelmann EP; Spiegel S
    Cancer Res; 2000 Aug; 60(16):4468-74. PubMed ID: 10969794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
    Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
    J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
    Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
    Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B.
    Beckham TH; Lu P; Cheng JC; Zhao D; Turner LS; Zhang X; Hoffman S; Armeson KE; Liu A; Marrison T; Hannun YA; Liu X
    Int J Cancer; 2012 Nov; 131(9):2034-43. PubMed ID: 22322590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells.
    Taniai T; Shirai Y; Shimada Y; Hamura R; Yanagaki M; Takada N; Horiuchi T; Haruki K; Furukawa K; Uwagawa T; Tsuboi K; Okamoto Y; Shimada S; Tanaka S; Ohashi T; Ikegami T
    Cancer Sci; 2021 Nov; 112(11):4570-4579. PubMed ID: 34459070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
    Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
    Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
    Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
    Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
    Separovic D; Breen P; Boppana NB; Van Buren E; Joseph N; Kraveka JM; Rahmaniyan M; Li L; Gudz TI; Bielawska A; Bai A; Bielawski J; Pierce JS; Korbelik M
    Int J Oncol; 2013 Dec; 43(6):2064-72. PubMed ID: 24126464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
    Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
    J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
    Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
    Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.